News summary

Digbi Health reports 18.4% weight loss in 3,181 GLP-1 users

Source: Longevity Technology • Published: 10 Nov 2026, 12:36

Summarized by Masters of Longevity from Longevity Technology.

A precision-care program reported 18.4% mean weight loss at 12 months in 3,181 users.

Digbi Health reports 18.4% weight loss in 3,181 GLP-1 users
Key Takeaways
  • Mean weight loss at 12 months was 18.4% among 3,181 members.
  • Participants were drawn from ten self-insured employer populations enrolled.
  • Findings are observational and do not establish causality.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.